Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,490 across all filing types
Latest filing 2024-04-22 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
(1) RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) CHANGES IN COMPOSITION OF BOARD COMMITTEE
Board/Management Information Classification · 100% confidence The document is an announcement from the board of 3SBio Inc. regarding the retirement of an independent non-executive director and changes in the composition of the board committee. It references the forthcoming AGM but does not contain any financial data or detailed report content. The document is short (2871 characters) and serves to inform shareholders and the market about board changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2024-04-22 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchases of shares on various dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and changes in issued shares, with no financial statements or earnings data. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-04-22 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases, which fits the category of Transaction in Own Shares (POS). The document length is sufficient and contains detailed transactional data, not just an announcement or certification, so it is not RNS or RPA.
2024-04-16 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchases of shares on specific dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and disclosures required by the exchange rules. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about share repurchases and capital changes, fitting the category of Transaction in Own Shares (POS). The document length is over 11,000 characters, indicating it is a full disclosure rather than a brief announcement. Therefore, the appropriate classification is POS with high confidence.
2024-04-15 English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HUMAN THROMBOPOIETIN INJECTION (TPIAO) OF 3SBIO APPROVED FOR PEDIATRIC ITP INDICATION
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding the approval of their Recombinant Human Thrombopoietin Injection (TPIAO) for pediatric ITP indication by the National Medical Products Administration (NMPA) of China. It includes a press release with details about the product, clinical studies, and statements from the Chairman and CEO. The document is relatively short (3899 characters) and serves as a news announcement about a regulatory approval rather than a financial report, earnings release, or detailed investor presentation. It does not contain financial data, management discussion, or voting results. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best under a Regulatory Filings (RNS) category as a general regulatory announcement about product approval and company update that does not fit other specific categories.
2024-04-12 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by 3SBio Inc. It details repurchases of shares on various dates, quantities, prices, and confirms compliance with listing rules of the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase transactions and capital changes, not on financial results, management commentary, or regulatory certifications. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is over 11,000 characters and contains detailed transactional data, confirming it is the report itself, not just an announcement or certification.
2024-04-12 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.